BEVACIZUMAB-MALY

201 reported adverse events

Drug classes: Vascular Endothelial Growth Factor Inhibitor [EPC]

These side effects are most commonly reported by patients taking BEVACIZUMAB-MALY:

# Side effect Count
0 DEATH 17
1 ASTHENIA 15
2 NAUSEA 11
3 NEUTROPENIA 11
4 DECREASED APPETITE 10
5 WEIGHT INCREASED 9
6 FATIGUE 8
7 ENCEPHALITIS 7
8 MUCOSAL INFLAMMATION 7
9 WEIGHT DECREASED 7
See all common reactions for BEVACIZUMAB-MALY

BEVACIZUMAB-MALY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT BILIARY OBSTRUCTION 1 0.0476
1 DUODENAL VARICES 1 0.0417
2 BETA-2 GLYCOPROTEIN ANTIBODY POSITIVE 1 0.0323
3 JEJUNAL ULCER PERFORATION 1 0.0217
4 AORTOENTERIC FISTULA 1 0.0156
5 CHORIORETINAL FOLDS 1 0.0141
6 IMMUNE-MEDIATED NEUROPATHY 1 0.0065
7 CARDIOLIPIN ANTIBODY POSITIVE 1 0.0055
8 C3 GLOMERULOPATHY 1 0.0048
9 INFUSION SITE PHLEBITIS 1 0.0044
See all enriched reactions for BEVACIZUMAB-MALY